Evidence map›Paper›PMID 25705891›Full record

ArticlePloS one2015

A distinct mechanism of vascular lumen formation in Xenopus requires EGFL7.

Marta S Charpentier, Panna Tandon, Claire E Trincot, Elitza K Koutleva, Frank L Conlon

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Evolution of Somite Compartmentalization: A View FromFrontiers in cell and developmental biology · 2021
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Marta S CharpentierUniversity of North Carolina McAllister Heart Institute, UNC-CH, Chapel Hill, North Carolina, United States of America; Department of Genetics and Molecular Biology, UNC-CH, Chapel Hill, North Carolina, United States of America.
Panna TandonUniversity of North Carolina McAllister Heart Institute, UNC-CH, Chapel Hill, North Carolina, United States of America; Department of Genetics and Molecular Biology, UNC-CH, Chapel Hill, North Carolina, United States of America.
Claire E TrincotUniversity of North Carolina McAllister Heart Institute, UNC-CH, Chapel Hill, North Carolina, United States of America; Department of Genetics and Molecular Biology, UNC-CH, Chapel Hill, North Carolina, United States of America.
Elitza K KoutlevaUniversity of North Carolina McAllister Heart Institute, UNC-CH, Chapel Hill, North Carolina, United States of America; Department of Biology, UNC-CH, Chapel Hill, North Carolina, United States of America.
Frank L ConlonUniversity of North Carolina McAllister Heart Institute, UNC-CH, Chapel Hill, North Carolina, United States of America; Department of Genetics and Molecular Biology, UNC-CH, Chapel Hill, North Carolina, United States of America; Department of Biology, UNC-CH, Chapel Hill, North Carolina, United States of America; Lineberger Comprehensive Cancer Center, UNC-CH, Chapel Hill, North Carolina, United States of America.
University of North Carolina Health Care · USUNC Lineberger Comprehensive Cancer Center

Funding

Craniofacial and cardiac development in Xenopus: A genetic approachR01DE018825 · NIDCR · UNIV OF NORTH CAROLINA CHAPEL HILL · PI CONLON, FRANK LEO, KHOKHA, MUSTAFA K · 2009 to 2013
$2.3M
TBX5 and cardiac proliferationR01HL089641 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI CONLON, FRANK LEO · 2008 to 2011
$1.5M
NHLBI NIH HHS R01 HL089641NIDCR NIH HHS R01 DE018825
6 · The paper itself

Abstract

During vertebrate blood vessel development, lumen formation is the critical process by which cords of endothelial cells transition into functional tubular vessels. Here, we use Xenopus embryos to explore the cellular and molecular mechanisms underlying lumen formation of the dorsal aorta and the posterior cardinal veins, the primary major vessels that arise via vasculogenesis within the first 48 hours of life. We demonstrate that endothelial cells are initially found in close association with one another through the formation of tight junctions expressing ZO-1. The emergence of vascular lumens is characterized by elongation of endothelial cell shape, reorganization of junctions away from the cord center to the periphery of the vessel, and onset of Claudin-5 expression within tight junctions. Furthermore, unlike most vertebrate vessels that exhibit specialized apical and basal domains, we show that early Xenopus vessels are not polarized. Moreover, we demonstrate that in embryos depleted of the extracellular matrix factor Epidermal Growth Factor-Like Domain 7 (EGFL7), an evolutionarily conserved factor associated with vertebrate vessel development, vascular lumens fail to form. While Claudin-5 localizes to endothelial tight junctions of EGFL7-depleted embryos in a timely manner, endothelial cells of the aorta and veins fail to undergo appropriate cell shape changes or clear junctions from the cell-cell contact. Taken together, we demonstrate for the first time the mechanisms by which lumens are generated within the major vessels in Xenopus and implicate EGFL7 in modulating cell shape and cell-cell junctions to drive proper lumen morphogenesis.

Indexed as

AnimalsCell ShapeClaudin-5Embryo, NonmammalianEndothelial CellsEndothelium, VascularExtracellular Matrix ProteinsMorphogenesisNeovascularization, PhysiologicTight JunctionsXenopus laevisXenopus ProteinsZonula Occludens-1 ProteinClaudin-5Egfl7 protein, XenopusExtracellular Matrix ProteinsTJP1 protein, XenopusXenopus ProteinsZonula Occludens-1 Protein

Identifiers

PMID25705891
PMCPMC4338030
OpenAlexW2086758270

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.